71
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

The Lipophilicity Parameters of New Antiproliferative 6,9-Disubstituted Quinobenzothiazines Determined by Computational Methods and RP TLC

, &
 

Abstract

The lipophilicity parameters (log Pcalcd, RM0, and log PTLC) of 54 new antiproliferative 6,9-disubstituted quinobenzothiazines were determined theoretically using eight computational methods and experimentally by reversed-phase thin-layer chromatography on the RP-18 silica plates with acetone-aqueous tris(hydroxymethyl)aminomethane buffer as mobile phase. The theoretical log Pcalcd values differed depending on the substituents and calculating programs. The experimental parameters RM0 and b (specific hydrophobic surface area) were intercorrelated showing congeneric classes of quinobenzothiazines. The parameter RM0 was further transformed into parameter log PTLC by use of the calibration curve. Generally, tetracyclic quinobenzothiazines turned out to be rather highly lipophilic compounds. The comparison of the calculated log Pcalcd and experimental log PTLC values showed different prediction power of the computational programs. The determined parameters were discussed in the terms of the structure–lipophilicity relationships. The RM0 values were correlated with molecular descriptors (molar mass, molar volume, and molar refractivity) and predicted and tested biological activities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.